1.Date of the board of directors' resolution:2023/03/09
2.Shareholders meeting date:2023/06/27
3.Shareholders meeting location:Howard Plaza Hotel 3F Dragon Hall
(located at No.160, Sec. 3, Ren Ai Road, Taipei City, Taiwan)
4.Shareholders' meeting will be held by means of (physical shareholders'
 meeting/ hybrid shareholders' meeting /
virtual-only shareholders' meeting):physical shareholders meeting
5.Cause for convening the meeting (1)Reported matters:
(1)2022 business report
(2)Audit Committee's review report on 2022 financial results
(3)2022 employees' and directors' and supervisors' remuneration
6.Cause for convening the meeting (2)Acknowledged matters:
(1)2022 Business Report and Financial Statements
(2)Distribution of 2022 Earnings
7.Cause for convening the meeting (3)Matters for Discussion:
(I)To authorize the Board of Directors to handle matters related of the cash
capital increase of Formosa Pharmaceuticals Inc. within the next year.
8.Cause for convening the meeting (4)Election matters:
To elect Independent Directors
9.Cause for convening the meeting (5)Other Proposals:
Proposed release the Directors and their representatives from
non-competition restrictions.
10.Cause for convening the meeting (6)Extemporary Motions:None
11.Book closure starting date:2023/04/29
12.Book closure ending date:2023/06/27
13.Any other matters that need to be specified:None